Effect of Sfrp5 on Cytokine Release and Insulin Action in Primary Human Adipocytes and Skeletal Muscle Cells

Autor: Christian Herder, Maren Carstensen, Michael Roden, Pia Fahlbusch, K. Röhrig, Claudia Wiza, D. Margriet Ouwens
Jazyk: angličtina
Rok vydání: 2014
Předmět:
Male
Anatomy and Physiology
medicine.medical_treatment
Glucose uptake
lcsh:Medicine
Mice
Endocrinology
Insulin Signaling Cascade
Molecular Cell Biology
Adipocytes
Insulin
lcsh:Science
Cells
Cultured

Multidisciplinary
biology
Chemistry
Middle Aged
Signaling Cascades
Cytokine
Phosphorylation
Medicine
Cytokines
Female
Research Article
Signal Transduction
Adult
medicine.medical_specialty
Adolescent
Adipokine
Endocrine System
Wnt-5a Protein
Young Adult
Internal medicine
Proto-Oncogene Proteins
medicine
Animals
Humans
Eye Proteins
Muscle
Skeletal

Biology
Adaptor Proteins
Signal Transducing

Diabetic Endocrinology
Inflammation
Muscle Cells
Adiponectin
Endocrine Physiology
Tumor Necrosis Factor-alpha
lcsh:R
Membrane Proteins
Diabetes Mellitus Type 2
Wnt Proteins
Insulin receptor
Glucose
biology.protein
lcsh:Q
Cytokine secretion
Zdroj: PLoS ONE
PLoS ONE, Vol 9, Iss 1, p e85906 (2014)
ISSN: 1932-6203
Popis: Secreted frizzled-related protein 5 (Sfrp5) is an adipokine with anti-inflammatory and insulin-sensitizing properties in mice. However, the mechanism of Sfrp5 action, especially in humans, is largely unknown. Therefore, cytokine release and insulin signaling were analyzed to investigate the impact of Sfrp5 on inflammation and insulin signaling in primary human adipocytes and skeletal muscle cells (hSkMC). Sfrp5 neither affected interleukin (IL)-6, monocyte chemoattractant protein-1 (MCP-1) and adiponectin release from human adipocytes, nor IL-6 and IL-8 release from hSkMC. In tumor necrosis factor (TNF) α-treated adipocytes, Sfrp5 reduced IL-6 release by 49% (p
Databáze: OpenAIRE